Wegovy

Page 2 of 6

A person, with only the midsection visible, injects Wegovy under the skin of their stomach.
Finance

Novo Nordisk stock surges 7% after Ozempic maker’s latest weight-loss drug shows promise

By
January 24, 2025
Eli Lilly & Co., the Fortune 500 pharma firm that manufactures weight-loss injection Zepbound (tirzepatide), has a comparable oral medication in the works that could be approved by the FDA as early as 2026, CEO Dave Ricks told Bloomberg TV on Jan. 13, 2025.
Health

Hate needles? Lilly’s weight-loss pill could get FDA approval next year, CEO says

By
January 22, 2025
Elon Musk admits he takes an Ozempic-like weight-loss drug that RFK Jr. wants to restrict
Health

Elon Musk admits he takes an Ozempic-like weight-loss drug that RFK Jr. wants to restrict

By
December 27, 2024
Novo Nordisk advertising flags and logo on facade, Danish pharmaceutical healthcare giant Novo Nordisk AS, production innovative drugs, obesity treatment Ozempic, Mainz, Germany June 15, 2024
Health

Novo Nordisk faces stock market bloodbath after weight-loss drug trial disappoints

By Ryan Hogg and AFP
December 20, 2024
Merck snags Chinese obesity drug in nearly $2 billion deal
Tech

Merck snags Chinese obesity drug in nearly $2 billion deal

By Robert Langreth and Bloomberg
December 19, 2024
Novo Nordisk invests $1.2 billion in new Danish factory to expand beyond insulin and weight-loss
Tech

Novo Nordisk invests $1.2 billion in new Danish factory to expand beyond insulin and weight-loss

By
December 16, 2024
Close-up of a patient administering a dose of Zepbound (tirzepatide)
Health

Zepbound vs. Wegovy: New clinical trial says this weight-loss medication sheds more pounds

By
December 4, 2024
Biden proposes Medicare and Medicaid cover weight-loss drugs like Wegovy and Ozempic for millions of obese Americans
Health

Biden proposes Medicare and Medicaid cover weight-loss drugs like Wegovy and Ozempic for millions of obese Americans

By Amanda Seitz and The Associated Press
November 26, 2024
High demand for weight loss drugs like Ozempic and Wegovy is impacting employer health care costs—but it can be critical for retaining talent
Leadership

High demand for weight loss drugs like Ozempic and Wegovy is impacting employer health care costs—but it can be critical for retaining talent

By
November 21, 2024
Novo Nordisk launches Wegovy in China with prices well below U.S.
Health

Novo Nordisk launches Wegovy in China with prices well below U.S.

By Amber Tong and Bloomberg
November 18, 2024
Novo Nordisk’s Wegovy sales jump on international rollouts
Retail

Novo Nordisk’s Wegovy sales jump on international rollouts

By Naomi Kresge and Bloomberg
November 6, 2024
Drugs like Ozempic and Wegovy are linked to a lower risk of Alzheimer’s disease, new study says
Health

Drugs like Ozempic and Wegovy are linked to a lower risk of Alzheimer’s disease, new study says

By
October 24, 2024
Ozempic and Wegovy are trimming waistlines—and showing how quickly U.S. health care can turn into a gold rush
Commentary

Ozempic and Wegovy are trimming waistlines—and showing how quickly U.S. health care can turn into a gold rush

By
October 23, 2024
Companies are more willing to consider covering weight-loss drugs
Health

Companies are more willing to consider covering weight-loss drugs

By
October 10, 2024
Despite the ubiquitousness of injectable GLP-1 drugs indicated for people with obesity, most Americans wouldn’t take them, according to a September 2024 survey from the Physicians Committee for Responsible Medicine.
Health

Most Americans who want to lose weight don’t want to take GLP-1 drugs like Wegovy and Zepbound, new survey says

By
October 10, 2024

Most Popular